Kivo reports a rise in FDA warning letters to drug firms due to documentation failures, with 94% citing recordkeeping issues.

Inconsistent reporting at a Pennsylvania site affected microbiological analyses of components and drug products that ...

Many laboratory instruments automatically record who did what and when. So, if everyone logs in with the same username and ...

Haemonetics stock edges higher on the day, trading at $118.73 while the PerQseal Elite system receives FDA approval.

Fractyl Health, Inc. stocks have been trading down by -68.51 percent amid heightened focus on its metabolic gene therapy ...

J&J's icotrokinra hit every UC endpoint in NEJM's Oct 2026 data, and the trial design choices behind that success are ...

The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...

AI can generate 100x more drug candidates, but trials still need real patients. The bottleneck has shifted, and most sponsors ...

Quick Fix Synthetic, the official distributor of Spectrum Labs' Quick Fix products, today corrected one of the most-repeated numbers in drug testing, using new data Quest Diagnostics quietly published ...

The company said the three data sets together give a clearer picture of the product it actually sells than any single ...

In AD, BioVie has conducted Phase 2 and Phase 3 trials. Preliminary data from these trials suggest improvements in cognition and biomarkers, supporting further trials to evaluate its potential as a ...

Federal recall records identify the USVI as a distribution area for ICU Medical IV tubing sets after reports of black specks ...